Results 241 to 250 of about 25,886 (305)

Better 10‐Year Cerebrovascular Outcome After Transplant Than on Standard‐Care in Sickle Cell Anemia: DREPAGREFFE Trial

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Management of cerebral vasculopathy in sickle cell anemia (SCA) includes standard‐care, that is, chronic transfusion (CT) or hydroxyurea, and hematopoietic cell transplantation (HCT). DREPAGREFFE‐1 (December 2010/June 2013), a French multicenter trial, was the first prospective trial comparing standard‐care to match sibling donor (MSD)‐HCT in ...
Francoise Bernaudin   +40 more
wiley   +1 more source

Written evidence submitted by The Foreign Policy Centre (MUL0018) [PDF]

open access: yes
Foreign Policy Center   +2 more
core  

Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I‐WISh) 2.0

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Limited data exist on how patients and physicians perceive immune thrombocytopenia (ITP) symptoms and treatment‐related burden. I‐WISh (ITP World Impact Survey) 2.0 surveyed 1018 patients and 431 physicians in 15 countries to characterize the impact of ITP and its treatments on patients.
Nichola Cooper   +17 more
wiley   +1 more source

Institutional capacity for non-communicable disease care in Ghana's primary health care system: a multi-method study. [PDF]

open access: yesBMC Prim Care
Adurayi Amenah M   +16 more
europepmc   +1 more source

Commodity risk assessment of <i>Salix</i> unrooted cuttings from the UK. [PDF]

open access: yesEFSA J
EFSA Panel on Plant Health (PLH)   +29 more
europepmc   +1 more source

Priorities for change for autistic people across Europe. [PDF]

open access: yesMol Autism
Binte Mohd Ikhsan SN   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy